Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katarzyna Reszka
Observed names:
K Reszka,
K. Reszka
Institution:
Medical University of Lublin
Observed institutions:
Poznan University of Medical Sciences,
Medical University of Lublin,
Samodzielny Publiczny Szpital Specjalistyczny Chorób Płuc im. dr O. Sokołowskiego,
Pomeranian Medical University
ORCID:
0000-0001-5612-1598
Observed ORCID:
0000-0001-5612-1598
OpenAlex ID:
A5029142660
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
2017
·
Pawel Krawczyk
, Dariusz M. Kowalski
, et al.
·
Oncology Letters
·
71
PDF
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
2021
·
Aleksandra Bożyk
, Paweł Krawczyk
, et al.
·
Archives of Medical Science
·
31
PDF
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
2021
·
Anna Grenda
, Paweł Krawczyk
, et al.
·
Frontiers in Oncology
·
24
PDF
Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients
2015
·
P. Krawczyk
, K. Reszka
, et al.
·
Annals of Oncology
·
23
PDF
Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinoma
2021
·
Anna Grenda
, Paweł Krawczyk
, et al.
·
Oncology Letters
·
20
PDF
PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients
2019
·
Paweł Krawczyk
, Anna Grenda
, et al.
·
Cancer Genetics
·
16
Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study
2018
·
Kamila Wojas-Krawczyk
, Ewa Kalinka-Warzocha
, et al.
·
Advances in Clinical and Experimental Medicine
·
16
PDF
[Influence of animal breeding manner on the occurence of internal parasites].
2004
·
Konstanty Romaniuk
, Katarzyna Reszka
, et al.
·
PubMed
·
15
Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes
2017
·
Paweł Krawczyk
, Bożena Jarosz
, et al.
·
Oncotarget
·
11
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
2022
·
Marcin Nicoś
, Luuk Harbers
, et al.
·
JTO Clinical and Research Reports
·
8
Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer
2015
·
Tomasz Powrózek
, Paweł Krawczyk
, et al.
·
Tumori Journal
·
8
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement
2021
·
Paweł Krawczyk
, Anna Grenda
, et al.
·
Scientific Reports
·
6
PDF
Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients
2018
·
Anna Grenda
, Bożena Jarosz
, et al.
·
Journal of Thoracic Disease
·
6
PDF
The efficacy of T790M mutation testing in liquid biopsy—Real clinic data
2022
·
Paweł Krawczyk
, Luiza Grzycka-Kowalczyk
, et al.
·
PLoS ONE
·
3
PDF
Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients—Real-World Evidence of Two Polish Cancer Centers
2025
·
Michał Gil
, Kinga Winiarczyk
, et al.
·
Cancers
·
2
PDF
Ocena rearanżacji genu ROS1 przy pomocy fluorescencyjnej hybrydyzacji in situ w niedrobnokomórkowym raku płuca
2020
·
Kamila Wojas-Krawczyk
, Patryk Jasielski
, et al.
·
Oncology in Clinical Practice
·
2
PDF
Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
2019
·
Marcin Nicoś
, Kamila Wojas-Krawczyk
, et al.
·
Archives of Medical Science
·
2
PDF
Epidermal growth factor receptor Mutation status: Does younger mean more frequently mutated?
2017
·
P Wójcik
, P Krawczyk
, et al.
·
Balkan Journal of Medical Genetics
·
2
PDF
Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma
2017
·
Marcin Nicoś
, Paweł Krawczyk
, et al.
·
Oncology in Clinical Practice
·
2
Mutational landscapes of brain metastases across various histological subtypes of lung cancer
2026
·
Marcin Nicoś
, Tomasz Stokowy
, et al.
·
Lung Cancer
·
1
Phenotypic variability in Arboleda-Tham syndrome: a report of a polish patient with a pathogenic KAT6A variant
2026
·
Joanna Rokosz-Mierzwa
, Katarzyna Reszka
, et al.
·
Molecular Biology Reports
Survival analysis of advanced lung cancer patients undergoing personalised treatment or chemotherapy in a real clinic
2021
·
Justyna Błach
, Paweł Krawczyk
, et al.
·
Archives of Medical Science
PDF
Poszukiwanie przyczyn oporności na immunoterapię pembrolizumabem u chorej na gruczołowego raka płuca z ekspresją PD-L1 – mikrobiom jelitowy „pod lupą”
2021
·
Anna Grenda
, Ewelina Iwan
, et al.
·
Oncology in Clinical Practice
PDF
P3.13-08 Assessment of EGFR Gene Mutations In cf-DNA in Monitoring of Response to EGFR TKIs in Patients with Lung Adenocarcinoma
2018
·
M. Nicoś
, K. Wojas-Krawczyk
, et al.
·
Journal of Thoracic Oncology
PDF
P1.13-14 The Molecular Landscape of Lung Adenocarcinomas with Activating EGFR Gene Mutations Determined by Targeted-Sequencing
2018
·
M. Nicoś
, K. Wojas-Krawczyk
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
30
Citation count:
269
H-index:
9
I10-index:
9
Year
Topic
Type